Rebus Holdings, Inc. (OTCPK: RBSH)
Health Care · Biotechnology · US
$0.00
— today · -99.0% 1Y
Rebus Holdings, Inc. (OTCPK: RBSH) operates in the Biotechnology industry within the Health Care sector. The company is valued at $32.00 and employs 1 people.
Over the last twelve months the share price has lost 99.0%, trading between 0.00 and 0.00.
Tweenvest scores Rebus Holdings, Inc. across four factors: quality 11/100, value 41/100. Its strongest factor is value.
RBSH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $32.00
- Revenue (TTM)
- —
- P/E
- 0.00
- EPS
- 0.02
- Dividend yield
- —
- Beta (5Y)
- -41.15
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 32.13M
- Employees
- 1
- Next earnings
- —
About Rebus Holdings, Inc.
Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerous growths, is engineered to diminish tumor invasion and improve therapeutic efficacy. The corporation was established in 2003 and maintains its headquarters in Westlake Village, California.
- ISIN
- US75619J1034
- Founded
- 2003
- Listed since
- Nov 4, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Gelesis Holdings, Inc.OTCPK: GLSH.Q | $73.00 | $0.00 | — |
| Athersys, Inc.OTCPK: ATHX.Q | $62.00 | $0.00 | -90.00% |
| Genocea Biosciences, Inc.OTCPK: GNCA.Q | $59.00 | $— | — |
| Mymetics CorporationOTCPK: MYMX | $46.00 | $— | — |
| HAVN Life Sciences Inc.OTCPK: HAVL.F | $29.00 | $— | — |
| IMV Inc.OTCPK: IMVI.F | $15.00 | $0.00 | — |
| PhaseRx, Inc.OTCPK: PZRX.Q | $12.00 | $— | — |
| ContraFect CorporationOTCPK: CFRX.Q | $11.00 | $— | — |
Figures last refreshed Oct 4, 2026.